Onychomycosis
📧 Sign up to get email alerts when something new happens for Onychomycosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Isotretinoin Versus Excimer Light an Adjuvant in Treating Onychomycosis [Phase 1]
Phase 1 trial evaluating isotretinoin versus excimer light as adjuvant therapy for onychomycosis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: An Open-label Study Evaluating the Effectiveness of CGB-400 Topical Gel for Fungal Infection
An open-label, completed study evaluating the effectiveness of CGB-400 Topical Gel for fungal nail infections.
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Safety, Tolerability and Efficacy of Trichostatin A in Patients With Mild to Severe Onychomycosis [Phase 2]
This document provides an update on a Phase 2 clinical trial evaluating safety, tolerability and efficacy of Trichostatin A for onychomycosi…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: A Phase 2 Study to Assess the Effectiveness of Topical Terbinafine in Participants With Mild to Moderate Onychomycosis of the Toenails [Phase 2]
Phase 2 clinical trial evaluating the effectiveness of topical terbinafine for mild to moderate toenail onychomycosis; the study is not yet …
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Study to Assess Efficacy, Safety and Tolerability of a Nail Patch in Patients With Nail Fragility, Mychosis, Psoriasis [Phase 3]
A Phase 3 clinical trial is evaluating the efficacy, safety, and tolerability of a Nail Patch for nail psoriasis, nail dystrophy/damage, and…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-09-12FDA Approved: TERBINAFINE HYDROCHLORIDE — Supplemental Application (Bionpharma Inc.)
FDA approved a supplemental application for Terbinafine hydrochloride from Bionpharma Inc., approving a generic antifungal product under the…
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: CLINICAL INVESTIGATION FOR THE EVALUATION OF EFFICACY AND SAFETY OF TWO PRODUCTS FOR THE TREATMENT OF ONYCHOMYCOSIS [NA]
Clinical trial update for two products being evaluated for efficacy and safety in treating onychomycosis; recruitment is ongoing.
-
CLINICAL_TRIALS trial_result · 2025-08-01Clinical Trial Update: Effect of the Erchonia® LunulaLaser™ for the Treatment of Toenail Onychomycosis [NA]
A clinical trial evaluating Erchonia's LunulaLaser for toenail onychomycosis was terminated. The trial's results were posted on 2025-08-01.
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: Exploring Different Dose-frequency Home Photodynamic Therapy Protocols Using a Novel Home-targeted LED Device for Onychomycosis [NA]
A clinical trial update evaluating different dose-frequency home photodynamic therapy protocols using a novel home-targeted LED device for o…
-
CLINICAL_TRIALS research · 2025-06-29Clinical Trial Update: Fractional CO₂ Laser or 40% Urea With Topical Fluconazole Microemulsion in Onychomycosis [NA]
A clinical trial evaluating fractional CO2 laser or 40% urea with topical fluconazole microemulsion for onychomycosis; the study status is n…
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: Study in Patients With Onychomycosis Treated With Mycoclear® and Ciclopirox
A University of Bologna-sponsored study evaluates Mycoclear in combination with ciclopirox for toenail onychomycosis; the trial is currently…
-
FDA approval · 2025-03-12FDA Approved: ITRACONAZOLE — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for itraconazole from Ascend Laboratories, LLC, authorizing changes to the generic product under AND…
-
FDA label_change · 2025-03-06FDA Approved: CICLOPIROX OLAMINE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a supplemental application for Ciclopirox Olamine filed by Padagis Israel Pharmaceuticals Ltd, resulting in changes to the prod…
-
CLINICAL_TRIALS trial_result · 2025-02-19Clinical Trial Update: A Study of ATB1651 in Adults With Mild to Moderate Onchomycosis [Phase 2]
A Phase 2 clinical trial evaluating ATB1651 for mild to moderate onychomycosis is currently recruiting.
-
FDA approval · 2025-01-29FDA Approved: ITRACONAZOLE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for itraconazole by Camber Pharmaceuticals, expanding/updating labeling for the generic product.
-
FDA approval · 2024-12-20FDA Approved: TERBINAFINE HYDROCHLORIDE — Supplemental Application (Breckenridge Pharmaceutical, Inc.)
FDA approved a supplemental application for a generic Terbinafine hydrochloride product from Breckenridge Pharmaceutical, Inc.
-
CLINICAL_TRIALS trial_result · 2024-11-18Clinical Trial Update: Pilot Study of Swift Microwave Device for Onychomycosis [Phase 1, Phase 2]
A pilot study evaluating a Swift Microwave Device for treating toenail onychomycosis (Phase 1 and Phase 2) has completed.
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: Spread of Dermatophytes Among Families
This completed clinical trial investigates the spread of dermatophyte infections within families and has posted results.
-
FDA approval · 2024-10-24FDA Approved: ITRACONAZOLE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved a supplemental application for itraconazole from Alembic Pharmaceuticals Inc., resulting in a label-related approval update for…
-
CLINICAL_TRIALS research · 2024-07-24Clinical Trial Update: Evaluation of a Combination of Two Medical Devices and One Device Use in the Treatment of Toenail Onychomycosis [NA]
Clinical trial update describing the evaluation of a combination of two medical devices and one device use for toenail onychomycosis. The st…
-
CLINICAL_TRIALS other · 2024-07-03Clinical Trial Update: Photodynamic Therapy and Topical Antifungal for Onychomycosis in Patients With Diabetes. [NA]
A clinical trial evaluating photodynamic therapy with a topical antifungal for toenail onychomycosis in patients with diabetes. The study is…
-
CLINICAL_TRIALS research · 2024-06-26Clinical Trial Update: A Vehicle-controlled Study of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO) [Phase 3]
Phase 3 vehicle-controlled trial investigating topical MOB015B for distal subungual onychomycosis is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Topical Application of Essential Oils to Treat Onchomycosis
Clinical trial is evaluating a topical essential oil formulation to treat toenail fungal infection (onychomycosis); the study is not yet rec…
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Mycosis Culture Collection From Dermatological Isolated
Clinical trial update about a mycosis culture collection from dermatological isolates; the study is active but not recruiting, focusing on o…
-
CLINICAL_TRIALS trial_result · 2024-03-18Clinical Trial Update: Efficacy and Safety Study of ME1111 in Patients With Onychomycosis [Phase 2]
Phase 2 trial results for ME1111 in onychomycosis reported completed with efficacy and safety data.